1.4.23 Use the same blood pressure targets for people with and without cardiovascular disease. [2022] For a short explanation of why the committee made the recommendation on blood pressure targets for people with cardiovascular disease and how this might affect practice, see the rationale and impact section on monitoring treatment and blood pressure targets for people with cardiovascular disease. Full details of the evidence and the committee's discussion are in the evidence review J: blood pressure targets. 1.4.24 Provide an annual review of care for adults with hypertension to monitor blood pressure, provide people with support, and discuss their lifestyle, symptoms and medication. [2004] Treatment review when type 2 diabetes is diagnosed 1.4.25 For an adult with type 2 diabetes on antihypertensive drug treatment when diabetes is diagnosed, review blood pressure control and medications used. Make changes only if there is poor control or if current drug treatment is not appropriate because of microvascular complications or metabolic problems. [2009] Choosing antihypertensive drug treatment (for people with or without type 2 diabetes) The recommendations in this section apply to people with hypertension with or without type 2 diabetes. They replace the recommendations on diagnosing and managing hypertension in NICE's guideline on type 2 diabetes in adults. For guidance on choosing antihypertensive drug treatment in people with type 1 diabetes, see also the section on control of cardiovascular risk in NICE's guideline on type 1 diabetes. Note that ACE inhibitors and angiotensin II receptor antagonists should not be used in pregnant or breastfeeding women or women planning pregnancy unless absolutely necessary, in which case the potential risks and benefits should be discussed. 